|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Other revenue | |||||
| Total revenue | |||||
| Cost of sales | |||||
| Selling, general and administrative expenses | |||||
| Goodwill impairment | |||||
| Transition services agreement income, net | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Other (income) expense, net | |||||
| Income from continuing operations before income taxes | |||||
| Provision for income taxes | |||||
| Income from continuing operations | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Basic earnings (loss) per share of common stock: | |||||
| Continuing operations (usd per share) | |||||
| Discontinued operations (usd per share) | |||||
| Total basic earnings (loss) per share of common stock (usd per share) | |||||
| Diluted earnings (loss) per share of common stock: | |||||
| Continuing operations (usd per share) | |||||
| Discontinued operations (usd per share) | |||||
| Total diluted earnings (loss) per share of common stock (usd per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
